Literature DB >> 21058584

The reliability of three visual perception tests used to assess adults.

Ted Brown1, Ralda Bourne, Emma Sutton, Stefan Wigg, Deidre Burgess, Sharon Glass, Stephen Elliott, Aislinn Lalor.   

Abstract

Summary.-The reliability of three adult visual perceptual tests was investigated. Participants aged 20 years and older (N = 221; 49 adults with neurological impairment, 172 adults without) completed the Developmental Test of Visual Perception-Adolescent and Adult (DTVP-A), the Motor-Free Visual Perception Test-3 (MVPT-3), and the Test of Visual Perceptual Skills (non-motor) Third Edition (TVPS-3). Participants (n = 46) without neurological impairment completed these tests twice. Cronbach's alpha for the DTVP-A, MVPT-3, and TVPS-3 total scales were .86, .74, and .80 and test-retest correlations .51, .71, and .72, respectively.

Entities:  

Mesh:

Year:  2010        PMID: 21058584     DOI: 10.2466/03.24.27.PMS.111.4.45-59

Source DB:  PubMed          Journal:  Percept Mot Skills        ISSN: 0031-5125


  4 in total

1.  Test-retest reliability and practice effect of the Leuven Perceptual Organisation Screening Test.

Authors:  Xiaotong Ding; Kathleen Vancleef
Journal:  Behav Res Methods       Date:  2022-01-11

2.  A participatory approach to develop the Power Mobility Screening Tool and the Power Mobility Clinical Driving Assessment tool.

Authors:  Deepan C Kamaraj; Brad E Dicianno; Rory A Cooper
Journal:  Biomed Res Int       Date:  2014-09-08       Impact factor: 3.411

3.  Relationships between cognitive functioning and power wheelchair performance, confidence and life-space mobility among experienced power wheelchair users: An exploratory study.

Authors:  Alice Pellichero; Krista Best; Jean Leblond; Pauline Coignard; Éric Sorita; François Routhier
Journal:  J Rehabil Med       Date:  2021-09-09       Impact factor: 2.912

4.  Delayed gait recovery in a stroke patient.

Authors:  Jeong Pyo Seo; Mi Young Lee; Yong Hyun Kwon; Sung Ho Jang
Journal:  Neural Regen Res       Date:  2013-06-05       Impact factor: 5.135

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.